DK270389A - Lyofiliseret igm-koncentrat - Google Patents

Lyofiliseret igm-koncentrat Download PDF

Info

Publication number
DK270389A
DK270389A DK270389A DK270389A DK270389A DK 270389 A DK270389 A DK 270389A DK 270389 A DK270389 A DK 270389A DK 270389 A DK270389 A DK 270389A DK 270389 A DK270389 A DK 270389A
Authority
DK
Denmark
Prior art keywords
compositions
prepared
weight
igm
lyofilized
Prior art date
Application number
DK270389A
Other languages
English (en)
Other versions
DK270389D0 (da
Inventor
Michael S Collins
John L Lundblad
Hans Georg Opitz
Richard L Seng
Original Assignee
Miles Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Miles Inc filed Critical Miles Inc
Publication of DK270389D0 publication Critical patent/DK270389D0/da
Publication of DK270389A publication Critical patent/DK270389A/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Peptides Or Proteins (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DK270389A 1988-06-06 1989-06-02 Lyofiliseret igm-koncentrat DK270389A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US20337788A 1988-06-06 1988-06-06

Publications (2)

Publication Number Publication Date
DK270389D0 DK270389D0 (da) 1989-06-02
DK270389A true DK270389A (da) 1989-12-07

Family

ID=22753737

Family Applications (1)

Application Number Title Priority Date Filing Date
DK270389A DK270389A (da) 1988-06-06 1989-06-02 Lyofiliseret igm-koncentrat

Country Status (8)

Country Link
EP (1) EP0345543B1 (da)
JP (1) JP2703341B2 (da)
AT (1) ATE112688T1 (da)
DE (1) DE68918761T2 (da)
DK (1) DK270389A (da)
ES (1) ES2060695T3 (da)
IE (1) IE64523B1 (da)
IL (1) IL90281A (da)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3825429C2 (de) * 1988-07-27 1994-02-10 Biotest Pharma Gmbh Verfahren zur Herstellung eines intravenös verabreichbaren polyklonalen Immunglobulin-Präparates mit hohem IgM-Gehalt
US5029840A (en) * 1988-08-30 1991-07-09 Ricoh Company, Ltd. Automatic sheet feeder for an image recording apparatus
DK0764658T3 (da) * 1995-09-22 2002-04-22 Zlb Bioplasma Ag Fremgangsmåde til fremstilling af immunoglobuliner ud fra fraktioner, som opstår ved fraktionering af blodplasma fra mennesker
JP4688457B2 (ja) * 2004-09-10 2011-05-25 四国乳業株式会社 免疫増強組成物
GB201006753D0 (en) 2010-04-22 2010-06-09 Biotest Ag Process for preparing an immunolobulin composition
US10570194B2 (en) 2015-08-06 2020-02-25 Grifols Worldwide Operations Limited Method for treating infectious diseases using a composition comprising plasma-derived immunoglobulin M (IgM)
EP3275897A1 (en) 2016-07-27 2018-01-31 Biotest AG Process for preparing immunoglobulin compositions
CN112409477B (zh) * 2019-08-21 2022-11-08 广东菲鹏生物有限公司 IgM纯化方法
KR20220166819A (ko) * 2020-04-10 2022-12-19 바누디스 게엠베하 예방 및 치료에서의 천연 항체
EP4178978A1 (en) * 2020-07-10 2023-05-17 Grifols Worldwide Operations Limited Method for obtaining a composition comprising human plasma-derived immunoglobulin m

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3597409A (en) * 1970-05-25 1971-08-03 American Cyanamid Co Process for recoverring immunoglobulin a and immunoglobulin m
US3808189A (en) * 1973-03-15 1974-04-30 American Cyanamid Co Isolation of gamma globulin preparations enriched in iga and igm using polyethylene glycol
US4604235A (en) * 1984-05-23 1986-08-05 J. T. Baker Chemical Company Purification of monoclonal antibodies

Also Published As

Publication number Publication date
JPH0267228A (ja) 1990-03-07
IL90281A (en) 1994-10-07
IE64523B1 (en) 1995-08-09
IL90281A0 (en) 1989-12-15
DE68918761T2 (de) 1995-02-16
EP0345543A3 (en) 1990-06-13
JP2703341B2 (ja) 1998-01-26
DE68918761D1 (de) 1994-11-17
ES2060695T3 (es) 1994-12-01
ATE112688T1 (de) 1994-10-15
EP0345543B1 (en) 1994-10-12
IE891805L (en) 1989-12-06
EP0345543A2 (en) 1989-12-13
DK270389D0 (da) 1989-06-02

Similar Documents

Publication Publication Date Title
Lindahl et al. Interferon treatment of mice: enhanced expression of histocompatibility antigens on lymphoid cells.
NO2007012I1 (no) Trastuzumab eller farmasoytisk akseptable salter derav
EP0673255A4 (en) MONOCLONAL ANTIBODY, WHICH SPECIFICALLY BINDS TO VASCULARIZED TUMOR DOTHELIUM AND USES THEREOF.
DK270389D0 (da) Lyofiliseret igm-koncentrat
ES2067600T3 (es) Procedimiento para la fabricacion de preparados de inmunoglobulina, que contienen igm y/o iga, no modificados de administracion intravenosa.
Liu et al. Remission of leukemia and loss of feline leukemia virus in cats injected with Staphylococcus protein A: association with increased circulating interferon and complement-dependent cytotoxic antibody.
US4844895A (en) Composition containing a peptide fragment of platelet factor four and method for restoring suppressed immune responses
US5510465A (en) Heat-treated IgM antibody preparations
AU2032988A (en) A genus-specific listeria antigen identified by monoclonal antibodies
Lindahl et al. Enhanced expression of histocompatibility antigens of lymphoid cells in mice treated with interferon
Harvath et al. Evaluation of type-specific and non-type-specific pseudomonas vaccine for treatment of pseudomonas sepsis during granulocytopenia
SE9300139L (sv) Framställning av ett nytt läkemedel
DE69126486T2 (de) Induzierung eines schutzes gegen virale infektionen
ATE175357T1 (de) Empfängnisverhütender impfstoff
Bhoopalam et al. Effect of dextran-S (alpha, 1-3 dextran) on the growth of plasmacytomas MOPC-104E and J558.
Lim et al. Biliary secretory IgA levels in rats with protein-calorie malnutrition.
Toyama et al. Inhibition of Sendai virus-induced hemolysis by concanavalin A
Mazumder et al. 1006 IMMUNE RECONSTITUTION IN PRIMARY IMMUNODEFICIENCIES BY INTERLEUKIN-2 (IL-2)
Moen et al. 1008 THEORETICAL AND BIOLOGICAL CONSIDERATIONS IN SUCCESSFUL MISMATCHED BONE MARROW TRANSPLANTATION
Mann et al. 1005 IN VITRO EFFECTS OF COMMERCIAL FACTOR VIII CONCENTRATES (FC) ON THE FUNCTION OF NORMAL LYMPHOCYTES
McClead et al. 1007 ORAL ANTI-PSEUUOMONAS (Ps) IgG PROVIDE SPECIFIC IMMUNE PROTECTION AGAINST PS SEPSIS DURING CYCLOPHOSPHAMIDE-INDUCED LEUKOPENIA
JPS6475433A (en) Remedy for herpes simplex virus infection
Magilavy et al. 1004 RETICULOENDOTHELIAL ACTIVATION, DIVERSITY IN MACRO-PHAGE SUBPOPULATIONS
Leiekly et al. 1003 SUCCESSFUL TREATMENT OF AUTOIMMUNE HEMOLYTIC ANEMIA (AIHA) IN COMMON VARIABLE IMMUNODEFICIENCY (CVID) WITH HIGH-DOSE INTRAVENOUS IMMUNE SLOBULIN (IVIS)
DA RHEUMATOID FACTOR.